|
|
Vaccine Detail
|
Recombinant SARS-CoV-2 vaccine (Sf9 cell) |
| Vaccine Information |
- Vaccine Name: Recombinant SARS-CoV-2 vaccine (Sf9 cell)
- Target Pathogen: SARS-CoV-2
- Target Disease: COVID-19
- Manufacturer: West China Hospital, Sichuan University
- Vaccine Ontology ID: VO_0005095
- Type: Subunit vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Immunization Route: Intramuscular injection (i.m.)
|
| Host Response |
|
|
| References |
|
|
|
